Answers are grounded in this paper and cite their sources.
This review analyzes genetic and epigenetic factors in idiopathic scoliosis, highlighting implications for precision medicine.
Idiopathic scoliosis (IS) is a complex, multifactorial spinal deformity with a largely elusive etiology. This review synthesizes current research on the genetic and epigenetic factors contributing to IS development and progression. Genome-wide association studies have identified key susceptibility loci—such as LBX1, GPR126, and BNC2—while family and twin studies underscore a significant heritable component. Chromosomal anomalies and polygenic interactions further complicate the genetic landscape. Concurrently, epigenetic mechanisms—including DNA methylation, histone modifications, and non-coding RNAs—have emerged as critical mediators of gene-environment interactions, influenced by factors such as mechanical load, nutrition, and endocrine disruptors. Multi-omic approaches integrating genomics, transcriptomics, and epigenomics offer new insights into pathophysiology and therapeutic targeting. Ethical considerations surrounding genetic testing and the need for population-specific models are also discussed. Ultimately, this review supports a shift toward precision medicine, highlighting the potential of early molecular biomarkers and epigenetic modulation as tools for individualized scoliosis management and intervention.
No takes yet. Share an insight, caveat, or question.
Mark W. Morningstar (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: